Sánchez-Valle Raquel, Monté Gemma C, Sala-Llonch Roser, Bosch Beatriz, Fortea Juan, Lladó Albert, Antonell Anna, Balasa Mircea, Bargalló Nuria, Molinuevo José Luis
Alzheimer's Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Clínic, Barcelona, Spain.
Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
J Alzheimers Dis. 2016;51(3):827-35. doi: 10.3233/JAD-150899.
PSEN1 mutations are the most frequent cause of autosomal dominant Alzheimer's disease (ADAD), and show nearly full penetrance. There is presently increasing interest in the study of biomarkers that track disease progression in order to test therapeutic interventions in ADAD. We used white mater (WM) volumetric characteristics and diffusion tensor imaging (DTI) metrics to investigate correlations with the normalized time to expected symptoms onset (relative age ratio) and group differences in a cohort of 36 subjects from PSEN1 ADAD families: 22 mutation carriers, 10 symptomatic (SMC) and 12 asymptomatic (AMC), and 14 non-carriers (NC). Subjects underwent a 3T MRI. WM morphometric data and DTI metrics were analyzed. We found that PSEN1 MC showed significant negative correlation between fractional anisotropy (FA) and the relative age ratio in the genus and body of corpus callosum and corona radiate (p < 0.05 Family-wise error correction (FWE) at cluster level) and positive correlation with mean diffusivity (MD), axial diffusivity (AxD), and radial diffusivity (RD) in the splenium of corpus callosum. SMC presented WM volume loss, reduced FA and increased MD, AxD, and RD in the anterior and posterior corona radiate, corpus callosum (p < 0.05 FWE) compared with NC. No significant differences were observed between AMC and NC in WM volume or DTI measures. These findings suggest that the integrity of the WM deteriorates linearly in PSEN1 ADAD from the early phases of the disease; thus DTI metrics might be useful to monitor the disease progression. However, the lack of significant alterations at the preclinical stages suggests that these indexes might not be good candidates for early markers of the disease.
早老素1(PSEN1)突变是常染色体显性阿尔茨海默病(ADAD)最常见的病因,且几乎具有完全外显率。目前,为了在ADAD中测试治疗干预措施,人们对追踪疾病进展的生物标志物的研究兴趣日益浓厚。我们使用白质(WM)体积特征和扩散张量成像(DTI)指标,在一个来自PSEN1 ADAD家族的36名受试者队列中,研究其与预期症状出现的标准化时间(相对年龄比)的相关性以及组间差异:22名突变携带者,其中10名有症状(SMC)和12名无症状(AMC),以及14名非携带者(NC)。受试者接受了3T磁共振成像(MRI)检查。分析了WM形态学数据和DTI指标。我们发现,PSEN1突变携带者在胼胝体膝部和体部以及放射冠中,分数各向异性(FA)与相对年龄比之间存在显著负相关(p < 0.05,聚类水平的家族性错误校正(FWE)),并且在胼胝体压部中与平均扩散率(MD)、轴向扩散率(AxD)和径向扩散率(RD)呈正相关。与NC相比,SMC在前、后放射冠和胼胝体中出现WM体积减少、FA降低以及MD、AxD和RD增加(p < 0.05,FWE)。在WM体积或DTI测量方面,未观察到AMC和NC之间存在显著差异。这些发现表明,在PSEN1 ADAD中,WM的完整性从疾病早期就开始线性恶化;因此,DTI指标可能有助于监测疾病进展。然而,临床前期缺乏显著改变表明这些指标可能不是该疾病早期标志物的良好候选者。